Literature DB >> 16802840

Developing health-related quality-of-life instruments for use in Asia: the issues.

Yin Bun Cheung1, Julian Thumboo.   

Abstract

About half of the world's population live in Asia. Mandarin (the official language of China), Hindi and Japanese are among the ten languages spoken by the largest number of primary speakers. The numbers of Tamil and Malay speakers are expected to grow rapidly in the next few decades. Most health-related quality-of-life (HR-QOL) instruments currently used in Asia are translations and/or adaptations of instruments developed in North America and Western Europe. We illustrate and discuss several major issues in the development of HR-QOL instruments for use in Asia. We have seen insufficient quality in translation and semantic equivalence, which is not a uniquely Asian problem. This problem will be alleviated by putting recently proposed guidelines for translation and adaptation of patient-reported outcomes into practice and formally conducting equivalence studies. For copyright or other reasons it is rare to see major adaptations, such as exclusion of a domain in the original instrument or inclusion of a new domain, made to existing instruments. Evidence is limited and mixed as to whether there are differences in the concepts of HR-QOL between Asian and North American/Western European cultures that are important enough to justify such major adaptations, or the development of indigenous instruments, as opposed to the translation/adaptation of existing instruments. There are substantial cultural differences concerning what questions are appropriate to ask and answer. Many HR-QOL instruments are designed for self-completion. This mode of administration is often not feasible in Asia because of low literacy rates and the presence of many different regional languages. Alternative administration methods and analytic strategies that allow for pooling data collected by different modes are needed. The availability of HR-QOL instruments in various Asian countries seems to reflect the status of economic development of the countries rather than their disease burden. For instance, many important HR-QOL instruments are available in Japanese but not in Hindi or Tamil.

Entities:  

Mesh:

Year:  2006        PMID: 16802840     DOI: 10.2165/00019053-200624070-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  28 in total

Review 1.  Health-related quality-of-life assessments in diverse population groups in the United States.

Authors:  A L Stewart; A Nápoles-Springer
Journal:  Med Care       Date:  2000-09       Impact factor: 2.983

2.  Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire.

Authors:  Morten Aa Petersen; Mogens Groenvold; Jakob B Bjorner; Neil Aaronson; Thierry Conroy; Ann Cull; Peter Fayers; Marianne Hjermstad; Mirjam Sprangers; Marianne Sullivan
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

3.  The equivalence of English and Chinese SF-36 versions in bilingual Singapore Chinese.

Authors:  Julian Thumboo; Kok-Yong Fong; Siew-Pang Chan; David Machin; Pao-Hsii Feng; Szu-Tien Thio; Mee-Leng Boey
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

4.  Are English- and Chinese-language versions of the SF-6D equivalent? A comparison from a population-based study.

Authors:  Hwee-Lin Wee; Yin-Bun Cheung; Kok-Yong Fong; Nan Luo; David Machin; Julian Thumboo
Journal:  Clin Ther       Date:  2004-07       Impact factor: 3.393

5.  Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey.

Authors:  C L Lam; B Gandek; X S Ren; M S Chan
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

Review 6.  Incomplete quality of life data in randomized trials: missing items.

Authors:  P M Fayers; D Curran; D Machin
Journal:  Stat Med       Date:  1998 Mar 15-Apr 15       Impact factor: 2.373

7.  Measuring quality of life in different cultures: translation of the Functional Living Index for Cancer (FLIC) into Chinese and Malay in Singapore.

Authors:  C R Goh; K S Lee; T C Tan; T L Wang; C H Tan; J Wong; P T Ang; M E Chan; J Clinch; C L Olweny; H Schipper
Journal:  Ann Acad Med Singapore       Date:  1996-05       Impact factor: 2.473

8.  Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.

Authors:  Diane Wild; Alyson Grove; Mona Martin; Sonya Eremenco; Sandra McElroy; Aneesa Verjee-Lorenz; Pennifer Erikson
Journal:  Value Health       Date:  2005 Mar-Apr       Impact factor: 5.725

9.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

10.  Quality of life among people living with HIV/AIDS in northern Thailand: MOS-HIV Health Survey.

Authors:  Masao Ichikawa; Chawalit Natpratan
Journal:  Qual Life Res       Date:  2004-04       Impact factor: 4.147

View more
  14 in total

1.  Exploration of a cultural-adaptation of the EQ-5D for Thai population: A "bolt-on" experiment.

Authors:  Krittaphas Kangwanrattanakul; Cynthia R Gross; Montaya Sunantiwat; Montarat Thavorncharoensap
Journal:  Qual Life Res       Date:  2018-12-05       Impact factor: 4.147

2.  Health-related quality of life measured using EQ-5D in patients with lymphomas.

Authors:  Richard Huan Xu; Eliza Lai-Yi Wong; Jun Jin; Huiqiang Huang; Dong Dong
Journal:  Support Care Cancer       Date:  2020-09-19       Impact factor: 3.603

3.  An audit of diabetes-dependent quality of life in patients with type 2 diabetes mellitus in Malaysia.

Authors:  Zeinab Jannoo; Bee Wah Yap; Kamarul Imran Musa; Mohamad Alias Lazim; Mohamed Azmi Hassali
Journal:  Qual Life Res       Date:  2015-03-24       Impact factor: 4.147

4.  Validation of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0 in English- and Chinese-speaking patients in a multi-ethnic Singapore systemic sclerosis cohort.

Authors:  Andrea Hsiu Ling Low; Xiaohui Xin; Weng Giap Law; Gim Gee Teng; Amelia Santosa; Anita Lim; Grace Chan; Swee Cheng Ng; Julian Thumboo
Journal:  Clin Rheumatol       Date:  2017-01-05       Impact factor: 2.980

5.  Derivation, and establishment of the validity and reliability, of the CASP-11-SG quality of life scale among community-dwelling older adults.

Authors:  Li Ting Tan; Truls Østbye; Abhijit Visaria; Rahul Malhotra
Journal:  Qual Life Res       Date:  2022-09-06       Impact factor: 3.440

6.  Prospective assessment of time-dependent changes in quality of life of Japanese patients with prostate cancer following robot-assisted radical prostatectomy.

Authors:  Hideaki Miyake; Akira Miyazaki; Junya Furukawa; Nobuyuki Hinata; Masato Fujisawa
Journal:  J Robot Surg       Date:  2016-02-17

7.  Japanese translation and linguistic validation of the Prosthetic Limb Users Survey of Mobility (PLUS-M).

Authors:  Geoffrey S Balkman; Soshi Samejima; Kazuki Fujimoto; Brian J Hafner
Journal:  Prosthet Orthot Int       Date:  2022-02-01       Impact factor: 1.672

8.  Exploratory analysis of health-related quality of life among the empty-nest elderly in rural China: an empirical study in three economically developed cities in eastern China.

Authors:  Ying Liang; Wei Wu
Journal:  Health Qual Life Outcomes       Date:  2014-04-25       Impact factor: 3.186

9.  Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQoL Group's 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population.

Authors:  Yin Bun Cheung; Nan Luo; Raymond Ng; Chun Fan Lee
Journal:  Health Qual Life Outcomes       Date:  2014-12-12       Impact factor: 3.186

10.  Translation and validation of the Farage Quality of Life (FQoL™) instrument for consumer products into traditional Chinese.

Authors:  Miranda A Farage; Cindy Rodenberg; Jasmine Chen
Journal:  Glob J Health Sci       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.